Division of Infectious Diseases

May 1, 2014

Cutting-edge research to be showcased in May

By Bill Snyder
April 24, 2014

Schaffner honored by pharmacy association

William Schaffner, M.D., professor of Preventive Medicine at Vanderbilt University Medical Center, received the Immunization Champion Award — Friend of Pharmacy from the American Pharmacists Association (APA) at the group’s annual meeting recently in Orlando, Fla.

By Chanler Knowles
January 30, 2014

AIDS Clinical Trials Unit lands renewal of NIH funding

Vanderbilt University’s AIDS Clinical Trials Unit (ACTU) has received a seven-year grant renewal from the National Institutes of Health (NIH).

By Bill Snyder
January 23, 2014

Human and Helicobacter co-evolution

By VUMC News and Communications
HIV cell
January 15, 2014

HIV’s impact on B cells

Understanding how HIV infection affects immune system B cells may guide strategies for vaccine development.

By Leigh MacMillan
November 14, 2013

Aronoff to lead Division of Infectious Diseases

David Aronoff, M.D., has been named the new director of Vanderbilt University Medical Center’s Division of Infectious Diseases.

By Jessica Pasley
October 30, 2013

Preserving antibiotic arsenal for TB

Clinicians should be cautious about prescribing newer fluoroquinolone antibiotics to patients with TB risk factors; doing so may jeopardize the use of these agents against TB.
By Leigh MacMillan
April 4, 2013

Vanderbilt researchers work to balance flu vaccine debate

Research in the last two years to examine the effectiveness of the influenza vaccine has raised public doubt about the flu shot's effectiveness. But two Vanderbilt researchers co-wrote an editorial in the Journal of the American Medical Association (JAMA) recently to help balance the current debate.
By VUMC News and Communications
March 14, 2013

New center to focus on treating, preventing TB

Vanderbilt University has established a tuberculosis center to expand and extend efforts to improve the treatment and prevention of this often fatal disease here and around the world.
By Bill Snyder
March 14, 2013

Recruitments bolster personalized medicine initiative

VUMC’s personalized medicine effort is getting a major boost with the recruitment of two physician-scientists from Australia who will increase Vanderbilt’s strength in translational immunology, the translation of basic immunological discoveries into clinically useful tools.
By Nancy Humphrey
October 25, 2012

HIV/AIDS-related efforts in Africa get $7 million boost

Vanderbilt University has received a major federal grant — just more than $7 million in the first year — to extend HIV/AIDS-related technical assistance and training in the rural province of Zambézia, Mozambique.
By Bill Snyder
August 2, 2012

Early HIV treatment also can prevent TB: study

Anti-retroviral therapy can prevent tuberculosis, even in people with early HIV disease.
By Bill Snyder
1 … 9 10 11 12